Inventor
BANERJEE ABHISEK
IN20 patents
⚠️ This page may combine multiple inventors who share the name “BANERJEE ABHISEK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS9862715B2Jan 9, 2018
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO5 citations83
US9458114B2Oct 4, 2016
Quinazolines as potassium ion channel inhibitors
BRISTOL MYERS SQUIBB CO9 citations83
US8987311B2Mar 24, 2015
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO14 citations83
US10676460B2Jun 9, 2020
Quinazolines as potassium ion channel inhibitors
BRISTOL MYERS SQUIBB CO1 citations72
US9242975B2Jan 26, 2016
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO4 citations72
US9242976B2Jan 26, 2016
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US11008306B2May 18, 2021
Quinazolines as potassium ion channel inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US10227340B2Mar 12, 2019
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US10214511B2Feb 26, 2019
Quinazolines as potassium ion channel inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
AMGEN INC
8 patentsUS11236069B2Feb 1, 2022
KIF18A inhibitors
AMGEN INC4 citations71
US12441736B2Oct 14, 2025
KIF18A inhibitors
AMGEN INC1 citations63
US12459932B2Nov 4, 2025
KIF18A inhibitors
AMGEN INC1 citations61
US12509442B2Dec 30, 2025
KIF18A inhibitors
AMGEN INC0 citations59
US12054476B2Aug 6, 2024
KIF18A inhibitors
AMGEN INC1 citations59
US12441705B2Oct 14, 2025
KIF18A inhibitors
AMGEN INC0 citations51
US12540129B2Feb 3, 2026
KIF18A inhibitors
AMGEN INC0 citations50
US11572374B2Feb 7, 2023
N-cyano-7-azanorbornane derivatives and uses thereof
AMGEN INC0 citations47